Results 191 to 200 of about 25,326 (255)

A CRISPR-Cas13d cancer therapeutic enables selective elimination of uveal melanoma. [PDF]

Mol Ther Oncol
Stauber D, Sosnick L, Ma Y, Pimcharoen S, Lawanprasert A, Murthy N, Myung D, Qi LS.   +7 more
europepmc   +1 more source

Competing risk analysis of prognosis in patients with uveal melanoma. [PDF]

Discov Oncol
Huang R, Chen J, Lyu J, Zhou Q, Lin L.
europepmc   +1 more source

Nine familial exterminations: Cas13d eliminates uveal melanoma cells through collateral RNA degradation. [PDF]

Mol Ther Oncol
Zheng D, Gu B.
europepmc   +1 more source

Data-driven strategies for immunoradiotherapy in uveal melanoma: the role of artificial intelligence. [PDF]

Front Pharmacol
Gu D, Feng Y, Li H.
europepmc   +1 more source

Hepatic metastasis surveillance in uveal melanoma: a retrospective cohort study from a UK tertiary centre (2006-2022). [PDF]

Br J Cancer
Rea B, Salehi M, Maiter A, Ochieng L, Lanham S, Kang J, Sinha S, Hawthorn J, Gill A, Johns C, Campbell MJ, Harley U, Quhill H, Salvi S.   +13 more
europepmc   +1 more source

Effect of Social Determinants of Health and Geography on Uveal Melanoma. [PDF]

Clin Ophthalmol
Sureshkumar H, Kolla S, Erukulla R, Ma W, Alahmadi R, Sun J, Heiferman MJ.   +6 more
europepmc   +1 more source

Identification of targetable epigenetic vulnerabilities for uveal melanoma. [PDF]

Cell Death Dis
Yenisehirli G, Borges S, Braun SS, Zuniga AN, Quintana GI, Kutsnetsoff JN, Volonterio RL, Rodriguez S, Adis EV, Lopez S, Dollar JJ, Stathias V, Volmar CH, Karaca E, Brothers SP, Bilbao D, Harbour JW, Correa ZM, Kurtenbach S.   +18 more
europepmc   +1 more source

Clinical Applications of Artificial Intelligence in Uveal Melanoma. [PDF]

Anticancer Res
Chadwick WF, Ganesh S, Dadzie AK, Ebrahimi B, Rahimi M, Son T, Alahmadi R, Yao X, Heiferman MJ.   +8 more
europepmc   +1 more source

Yttrium-90 Radioembolization as a Safe and Effective Treatment Option for Hepatic Uveal Melanoma Metastases. [PDF]

Cardiovasc Intervent Radiol
Ni JR, Quirk M, Chmielowski B, Padia SA.
europepmc   +1 more source